Rock Creek Group LLC has filed a Form 13F-HR with the U.S. Securities and Exchange Commission, disclosing its equity securities holdings as of the close of business on September 30, 2026. The filing, signed by President and Chief Executive Officer Afsaneh Mashayekhi Beschloss, details the firm's investment portfolio for the specified period.
The report lists 65 separate equity securities held by the firm. The largest position disclosed is Actuate Therapeutics Inc., for which Rock Creek Group holds 50,000 shares. The firm also holds significant positions in Avantor Inc., with 29,257 shares, and Celsius Holdings Inc., with 10,000 shares.
Rock Creek Group's portfolio includes a mix of individual company stocks and exchange-traded funds (ETFs). Notable individual stock holdings include Choice Hotels International, Inc. (327,579 shares), Cellectis Ltd. (200,000 shares), and Five9 Inc. (60,000 shares). The firm also holds stakes in Flywire Corp, Griffon Corp, and Kyndryl Hldgs Inc.
In terms of ETFs, the firm holds substantial positions in the iShares Core S&P Total U.S. Stock Market ETF (746,655 shares) and the iShares Core S&P 500 ETF (18,667 shares). Other ETFs in the portfolio include the iShares MSCI Emerging Markets ex China ETF (49,981 shares), the iShares Core MSCI International ETF (575,428 shares), and the iShares Core MSCI EAFE ETF (87,016 shares).
The filing also includes a position in the RockCreek Global Equalizer ETF (307,7495 shares), which appears to be a fund managed by Rock Creek Group.
